Regulus Therapeutics to Present at the Oppenheimer 35th Annual Healthcare Life Sciences Conference

Group 1 - Regulus Therapeutics Inc. is a biopharmaceutical company focused on discovering and developing innovative medicines targeting microRNAs [3] - The management team will participate in a fireside chat at the Oppenheimer 35th Annual Healthcare Life Sciences Conference on February 11th at 2:40 p.m. ET [1] - The live event and replay will be available on the company's investor relations website for 90 days following the presentation [2] Group 2 - Regulus has developed a pipeline supported by a strong intellectual property estate in the microRNA field [3] - The company is headquartered in San Diego, CA [3]